[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

ICON Group International: Market Research Reports

ICON Group International, Inc.’s primary mission is to assist managers with their international information needs. U.S.-owned and operated, ICON Group has published thousands of multi-client databases and global/regional market data, industry, and country publications.

Publications found: 132,106
Sort by:

The 2023-2028 Outlook for Anti-Hypertensive Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-hypertensive drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (...

October 2022 502 pages

The 2023-2028 Outlook for Anti-Icing Coatings in the United States

US$ 595.00

This study covers the latent demand outlook for anti-icing coatings across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I....

October 2022 502 pages

The 2023-2028 Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-idiopathic pulmonary fibrosis drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential in...

October 2022 511 pages

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-inflammatory asthma drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ear...

October 2022 505 pages

The 2023-2028 Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics in the United States

US$ 595.00

This study covers the latent demand outlook for anti-inflammatory autoimmune disease therapeutics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or pot...

October 2022 515 pages

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-inflammatory Lupus drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earn...

October 2022 503 pages

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-inflammatory scleroderma drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industr...

October 2022 509 pages

The 2023-2028 Outlook for Anti-Inflammatory Therapeutics in the United States

US$ 595.00

This study covers the latent demand outlook for anti-inflammatory therapeutics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ear...

October 2022 505 pages

The 2023-2028 Outlook for Anti-Malarial Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-malarial drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I....

October 2022 502 pages

The 2023-2028 Outlook for Anti-Money Laundering Software in the United States

US$ 595.00

This study covers the latent demand outlook for anti-money laundering software across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ear...

October 2022 505 pages

The 2023-2028 Outlook for Anti-Obesity Prescription Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-obesity prescription drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ea...

October 2022 504 pages

The 2023-2028 Outlook for Anti-Parkinson's Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-Parkinson's drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P...

October 2022 502 pages

The 2023-2028 Outlook for Anti-Radiation Devices for Cell Phones in the United States

US$ 595.00

This study covers the latent demand outlook for anti-radiation devices for cell phones across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential indu...

October 2022 509 pages

The 2023-2028 Outlook for Anti-Reflective Coatings in the United States

US$ 595.00

This study covers the latent demand outlook for anti-reflective coatings across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings...

October 2022 502 pages

The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in the United States

US$ 595.00

This study covers the latent demand outlook for anti-rejection drugs and immunosuppressants for liver diseases treatments across the states and cities of the United States. Latent demand (in millions...

October 2022 515 pages

The 2023-2028 Outlook for Anti-Snoring Treatments in the United States

US$ 595.00

This study covers the latent demand outlook for anti-snoring treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (...

October 2022 502 pages

The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Diabetic Macular Edema Treatments in the United States

US$ 595.00

This study covers the latent demand outlook for anti-vascular endothelial growth factor (anti-VEGF) diabetic macular Edema treatments across the states and cities of the United States. Latent demand (...

October 2022 515 pages

The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States

US$ 595.00

This study covers the latent demand outlook for anti-vascular endothelial growth factor therapy (anti-VEGF) for non-infectious macular edema across the states and cities of the United States. Latent d...

October 2022 515 pages

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anti-viral nucleotide polymerase inhibitor drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or pote...

October 2022 515 pages

The 2023-2028 Outlook for Anti Wrinkles Products in the United States

US$ 595.00

This study covers the latent demand outlook for anti wrinkles products across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P...

October 2022 502 pages

The 2023-2028 Outlook for Antiaging Products and Services in the United States

US$ 595.00

This study covers the latent demand outlook for antiaging products and services across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ea...

October 2022 505 pages

The 2023-2028 Outlook for Antibacterial Hospital Acquired Pneumonia Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antibacterial hospital acquired pneumonia drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or poten...

October 2022 515 pages

The 2023-2028 Outlook for Antibacterials in the United States

US$ 595.00

This study covers the latent demand outlook for antibacterials across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) e...

October 2022 502 pages

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in the United States

US$ 595.00

This study covers the latent demand outlook for anticholinergic motion sickness treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential...

October 2022 515 pages

The 2023-2028 Outlook for Anticoagulant Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anticoagulant drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I....

October 2022 502 pages

The 2023-2028 Outlook for Anticoagulant Reversal Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for anticoagulant reversal drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earni...

October 2022 503 pages

The 2023-2028 Outlook for Anticoagulants in the United States

US$ 595.00

This study covers the latent demand outlook for anticoagulants across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) e...

October 2022 502 pages

The 2023-2028 Outlook for Anticoagulation Therapies in the United States

US$ 595.00

This study covers the latent demand outlook for anticoagulation therapies across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings...

October 2022 502 pages

The 2023-2028 Outlook for Anticonvulsants for Krabbe Disease Treatments in the United States

US$ 595.00

This study covers the latent demand outlook for anticonvulsants for Krabbe disease treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potenti...

October 2022 515 pages

The 2023-2028 Outlook for Antidepressant Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antidepressant drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I...

October 2022 502 pages

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antidepressant and anti-anxiety drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential indus...

October 2022 509 pages

The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States

US$ 595.00

This study covers the latent demand outlook for antidepressants for anxiety disorders across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential indus...

October 2022 509 pages

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States

US$ 595.00

This study covers the latent demand outlook for antidepressants for major depressive disorders across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potent...

October 2022 515 pages

The 2023-2028 Outlook for Antidiarrheal Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antidiarrheal drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I....

October 2022 502 pages

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antiemetic chemotherapy drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earn...

October 2022 505 pages

The 2023-2028 Outlook for Antiepileptic Therapeutics for Fibromyalgia in the United States

US$ 595.00

This study covers the latent demand outlook for antiepileptic therapeutics for fibromyalgia across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential...

October 2022 515 pages

The 2023-2028 Outlook for Antifibrinolytic Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antifibrinolytic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P...

October 2022 502 pages

The 2023-2028 Outlook for Antifungal Azole Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antifungal azole drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P...

October 2022 502 pages

The 2023-2028 Outlook for Antifungal Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antifungal drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.)...

October 2022 502 pages

The 2023-2028 Outlook for Antihypertensives in the United States

US$ 595.00

This study covers the latent demand outlook for antihypertensives across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E....

October 2022 502 pages

The 2023-2028 Outlook for Antimicrobial Susceptibility Testing in the United States

US$ 595.00

This study covers the latent demand outlook for antimicrobial susceptibility testing across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential indust...

October 2022 505 pages

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States

US$ 595.00

This study covers the latent demand outlook for antipsychotic drugs for schizophrenia across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential indus...

October 2022 509 pages

The 2023-2028 Outlook for Antipsychotic Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antipsychotic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I....

October 2022 502 pages

The 2023-2028 Outlook for Antipsychotics in the United States

US$ 595.00

This study covers the latent demand outlook for antipsychotics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) e...

October 2022 501 pages

The 2023-2028 Outlook for Antisense and RNAi Therapeutics in the United States

US$ 595.00

This study covers the latent demand outlook for antisense and RNAi therapeutics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ea...

October 2022 505 pages

The 2023-2028 Outlook for Antithrombin Therapeutics in the United States

US$ 595.00

This study covers the latent demand outlook for antithrombin therapeutics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings...

October 2022 502 pages

The 2023-2028 Outlook for Antiulcerant Drugs in the United States

US$ 595.00

This study covers the latent demand outlook for antiulcerant drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E...

October 2022 502 pages

The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States

US$ 595.00

This study covers the latent demand outlook for anxiety disorder treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnin...

October 2022 502 pages

The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States

US$ 595.00

This study covers the latent demand outlook for anxiety disorders and depression across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry e...

October 2022 505 pages

The 2023-2028 Outlook for Aortic Aneurysm in the United States

US$ 595.00

This study covers the latent demand outlook for aortic aneurysm across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.)...

October 2022 502 pages

Filters

Search

Categories

108,692
32
10
1
16,880
308
80
42
20
4
3
3
1
288
160
49
42
31
31
28
17
16
11
8
7
7
6
6
5
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
4
665
637
447
295
289
208
174
165
164
130
124
119
108
103
95
94
89
73
65
63
63
60
55
47
47
45
45
32
31
28
28
27
25
25
25
25
25
25
22
20
20
19
18
16
16
15
15
14
13
12
12
12
11
11
11
11
11
10
9
8
8
8
8
8
7
6
6
5
4
4
4
4
4
4
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
83
3

Publishers

132,106

Regions

22,940
11,471
11,471
11,471
74,753

Price

Date

Pages

Offers